Results 111 to 120 of about 24,005 (199)

Possible involvement of ROS generation in vorinostat pretreatment induced enhancement of the antibacterial activity of ciprofloxacin

Clinical Pharmacology: Advances and Applications, 2017
Majed M Masadeh,1 Karem H Alzoubi,2 Sayer I Al-azzam,2 Ahlam M Al-buhairan3 1Department of Pharmaceutical Technology, 2Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan; 3Department of Clinical Laboratory ...
Masadeh MM, Alzoubi KH, Al-azzam SI, Al-buhairan AM   +3 more
doaj  

Vorinostat [PDF]

, 2020
openaire   +1 more source

Screening of FDA-Approved Small Molecules to Discover Inhibitors of the <i>Pseudomonas aeruginosa</i> Quorum-Sensing Enzyme, PqsE. [PDF]

Biochemistry
Jones HA, Baxter MJ, Zimmermann N, Li A, Perrault Uptmor KA, Taylor IR.   +5 more
europepmc   +1 more source

Identification of Glutathione Synthetase as a Therapeutic Target for Cervical Cancer via Combining Bioinformatics and Experimental Validation. [PDF]

J Cell Mol Med
Pan M, Yi T, Lei P, Mo J, Lan J, Ye Y, Wang H, Yuan C, Huang Z.   +8 more
europepmc   +1 more source

A broad-spectrum antibiotic, DCAP, reduces uropathogenic Escherichia coli infection and enhances vorinostat anticancer activity by modulating autophagy [PDF]

, 2018
Allavena, Giulia, Debellis, Doriana, Grimaldi, Benedetto, Joshi, Chetanchandra S, Marotta, Roberto, Mysorekar, Indira U   +5 more
core   +1 more source

Isoform-specific vs. pan-histone deacetylase inhibition as approaches for countering glioblastoma: an <i>in vitro</i> study. [PDF]

Front Oncol
Joshi A, Ratnapradipa N, Hughes J, Moore E, Ekpenyong A, Shukla S.   +5 more
europepmc   +1 more source

HDAC inhibitors as anticancer drugs: chemical diversity, clinical trials, challenges and perspectives. [PDF]

RSC Adv
Abdallah AE.
europepmc   +1 more source

Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells [PDF]

, 2015

core   +1 more source

Synergistic anticancer effects of ABT-199 and Vorinostat encapsulated in PLGA nanoparticles: Formulation, characterization, and antiproliferative effects against colorectal cancer cells. [PDF]

PLoS One
Abu Alsamen DR, Zakaraya ZZ, Abed A, Alsa'd AA, Alnajdawi MR.   +4 more
europepmc   +1 more source

Correction: Gan et al. METTL3 Promotes Cutaneous T-Cell Lymphoma Progression by Regulating ARHGEF12 Expression. <i>Int. J. Mol. Sci.</i> 2025, <i>26</i>, 3640. [PDF]

Int J Mol Sci
Gan L, Kong Y, Shi H, Zhang C, Tian C, Chen H.   +5 more
europepmc   +1 more source